34 results
CORRESP
IMPL
Impel Pharmaceuticals Inc
2 Apr 21
Correspondence with SEC
12:00am
that the assessment as to whether an SAE is drug related or not is determined by each individual investigator on site. Further, as disclosed in the Registration
S-3
EX-4.3
IMPL
Impel Pharmaceuticals Inc
16 May 22
Shelf registration
4:49pm
by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise, all such liability being
10-K/A
2022 FY
IMPL
Impel Pharmaceuticals Inc
31 Mar 23
Annual report (amended)
4:21pm
(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness
8-K
EX-99.2
IMPL
Impel Pharmaceuticals Inc
18 Jan 22
Impel NeuroPharma Provides Updates on TrudhesaTM Launch
8:01am
as required by law. By attending or receiving this presentation you acknowledge that you will be solely responsible for your own assessment of the market
10-K
2021 FY
IMPL
Impel Pharmaceuticals Inc
29 Mar 22
Annual report
5:09pm
an assessment of the following long-term outcomes of Trudhesa when patients were treated for six months:
39% of patients treated with Trudhesa … assessment, reinforcement strategies, functional communication training, and the use of second-generation antipsychotics. With an increasing rate of ASD
8-K
EX-10.1
gcqejg q851l4dd
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
S-3
EX-1.2
e92d84tlq6w1dyt6m3
16 May 22
Shelf registration
4:49pm
S-1
qama2omp
2 Apr 21
IPO registration
3:04pm
424B1
licsp45ccq4a2zerb
23 Apr 21
Prospectus with pricing info
4:01pm
DRS/A
ep9r3o e46to3jl
23 Mar 21
Draft registration statement (amended)
12:00am
424B4
4fb6bk d5n1bvuw
10 Sep 21
Prospectus supplement with pricing info
4:01pm